Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03631199
Title Study of Efficacy and Safety of Pembrolizumab Plus Platinum-based Doublet Chemotherapy With or Without Canakinumab in Previously Untreated Locally Advanced or Metastatic Non-squamous and Squamous NSCLC Subjects (CANOPY-1)
Acronym CANOPY-1
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | NLD | ITA | GBR | FRA | ESP | DEU | CAN | AUT | AUS

Facility Status City State Zip Country Details
Pacific Shores Medical Group . Long Beach California 90813 United States Details
USC Kenneth Norris Comprehensive Cancer Center . Los Angeles California 90033 United States Details
Advent Health Cancer Institute Orlando Florida 32804 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02215 United States Details
Novartis Investigative Site Caba Buenos Aires C1426ANZ Argentina Details
Novartis Investigative Site Buenos Aires C1431FWO Argentina Details
Novartis Investigative Site Westmead New South Wales 2145 Australia Details
Novartis Investigative Site Wooloongabba Queensland 4102 Australia Details
Novartis Investigative Site Melbourne Victoria 3000 Australia Details
Novartis Investigative Site Murdoch Western Australia 6150 Australia Details
Novartis Investigative Site Linz Oberoesterreich A 4020 Austria Details
Novartis Investigative Site Salzburg 5020 Austria Details
Novartis Investigative Site Barretos SP 14784 400 Brazil Details
Novartis Investigative Site Sao Paulo SP 01246 000 Brazil Details
Novartis Investigative Site Sao Paulo SP 04014-002 Brazil Details
Novartis Investigative Site Edmonton Alberta T6G 1Z2 Canada Details
Novartis Investigative Site Brampton Ontario L6R 3J7 Canada Details
Novartis Investigative Site Toronto Ontario M5G 1Z6 Canada Details
Novartis Investigative Site Temuco Region De La Araucania 4810469 Chile Details
Novartis Investigative Site Santiago 8420383 Chile Details
Novartis Investigative Site Harbin Heilongjiang 150081 China Details
Novartis Investigative Site Wuhan Hubei 430022 China Details
Novartis Investigative Site Wuhan Hubei 430030 China Details
Novartis Investigative Site Changsha Hunan 410013 China Details
Novartis Investigative Site Changchun Jilin 130012 China Details
Novartis Investigative Site XI An Shanxi 710038 China Details
Novartis Investigative Site Hangzhou Zhejiang 310022 China Details
Novartis Investigative Site Beijing 100036 China Details
Novartis Investigative Site Valledupar Cesar 5602310 Colombia Details
Novartis Investigative Site Brno Czech Republic 656 53 Czechia Details
Novartis Investigative Site Prague 2 Czech Republic 128 00 Czechia Details
Novartis Investigative Site Brno - Bohunice 625 00 Czechia Details
Novartis Investigative Site Ostrava Vitkovice 703 84 Czechia Details
Novartis Investigative Site Herning 7400 Denmark Details
Novartis Investigative Site Oulu FIN-90220 Finland Details
Novartis Investigative Site Marseille cedex 20 Bouches Du Rhone 13915 France Details
Novartis Investigative Site Lyon 69373 France Details
Novartis Investigative Site Montpellier 34070 France Details
Novartis Investigative Site Paris 75231 France Details
Novartis Investigative Site Saint Herblain 44800 France Details
Novartis Investigative Site Berlin 13125 Germany Details
Novartis Investigative Site Dresden 01307 Germany Details
Novartis Investigative Site Essen 45147 Germany Details
Novartis Investigative Site Georgsmarienhuette 49124 Germany Details
Novartis Investigative Site Gerlingen 70839 Germany Details
Novartis Investigative Site Gottingen 37075 Germany Details
Novartis Investigative Site Halle (Saale) 06120 Germany Details
Novartis Investigative Site Heidelberg 69120 Germany Details
Novartis Investigative Site Koeln 50937 Germany Details
Novartis Investigative Site Koeln 51109 Germany Details
Novartis Investigative Site Leipzig D-04347 Germany Details
Novartis Investigative Site Muenchen 81377 Germany Details
Novartis Investigative Site Athens GR 115 27 Greece Details
Novartis Investigative Site Athens 18547 Greece Details
Novartis Investigative Site Kowloon Hong Kong Details
Novartis Investigative Site Veszprem 8200 Hungary Details
Novartis Investigative Site Reykjavik IS-101 Iceland Details
Novartis Investigative Site Hyderabad Andhra Pradesh 500 034 India Details
Novartis Investigative Site Gurgaon Haryana 122 001 India Details
Novartis Investigative Site Pune Maharashtra 411013 India Details
Novartis Investigative Site Jaipur Rajasthan 302017 India Details
Novartis Investigative Site Hyderabad Telangana 500082 India Details
Novartis Investigative Site Kolkata West Bengal 700160 India Details
Novartis Investigative Site Avellino AV 83100 Italy Details
Novartis Investigative Site Genova GE 16132 Italy Details
Novartis Investigative Site Milano MI 20132 Italy Details
Novartis Investigative Site Milano MI 20133 Italy Details
Novartis Investigative Site Milano MI 20141 Italy Details
Novartis Investigative Site Rozzano MI 20089 Italy Details
Novartis Investigative Site Modena MO 41100 Italy Details
Novartis Investigative Site Padova PD 35100 Italy Details
Novartis Investigative Site Perugia PG 06129 Italy Details
Novartis Investigative Site Parma PR 43100 Italy Details
Novartis Investigative Site Orbassano TO 10043 Italy Details
Novartis Investigative Site Nagoya Aichi 464 8681 Japan Details
Novartis Investigative Site Sapporo city Hokkaido 060 8648 Japan Details
Novartis Investigative Site Himeji Hyogo 670-8520 Japan Details
Novartis Investigative Site Yokohama-city Kanagawa 241-8515 Japan Details
Novartis Investigative Site Sakai Osaka 591-8555 Japan Details
Novartis Investigative Site Sunto Gun Shizuoka 411 8777 Japan Details
Novartis Investigative Site Chuo ku Tokyo 104 0045 Japan Details
Novartis Investigative Site Ube-city Yamaguchi 755-0241 Japan Details
Novartis Investigative Site Osaka 545-8586 Japan Details
Novartis Investigative Site Gyeonggi do Korea 10408 Korea, Republic of Details
Novartis Investigative Site Seoul Seocho Gu 06591 Korea, Republic of Details
Novartis Investigative Site Seoul 03080 Korea, Republic of Details
Novartis Investigative Site Seoul 03722 Korea, Republic of Details
Novartis Investigative Site Seoul 05505 Korea, Republic of Details
Novartis Investigative Site Ashrafieh 166830 Lebanon Details
Novartis Investigative Site Saida 652 Lebanon Details
Novartis Investigative Site Kuantan Pahang 25100 Malaysia Details
Novartis Investigative Site Kuching Sarawak 93586 Malaysia Details
Novartis Investigative Site Kuala Lumpur Wilayah Persekutuan 50586 Malaysia Details
Novartis Investigative Site Kuala Lumpur 59100 Malaysia Details
Novartis Investigative Site Groningen 9713 GZ Netherlands Details
Novartis Investigative Site Groningen 9728 NZ Netherlands Details
Novartis Investigative Site Drammen 3004 Norway Details
Novartis Investigative Site Taguig City Metro Manila 1634 Philippines Details
Novartis Investigative Site Makati City 1229 Philippines Details
Novartis Investigative Site Quezon 1102 Philippines Details
Novartis Investigative Site San Juan City 1500 Philippines Details
Novartis Investigative Site Gliwice 44 101 Poland Details
Novartis Investigative Site Poznan 60 569 Poland Details
Novartis Investigative Site Tomaszw Mazowiecki 97-200 Poland Details
Novartis Investigative Site Lisboa 1769-001 Portugal Details
Novartis Investigative Site Porto 4200-072 Portugal Details
Novartis Investigative Site Craiova Dolj 200347 Romania Details
Novartis Investigative Site Cluj-Napoca 400124 Romania Details
Novartis Investigative Site Arkhangelsk 163045 Russian Federation Details
Novartis Investigative Site Omsk 644013 Russian Federation Details
Novartis Investigative Site Pushkin Saint Petersburg 196603 Russian Federation Details
Novartis Investigative Site Saint Petersburg 197022 Russian Federation Details
Novartis Investigative Site St Petersburg 192148 Russian Federation Details
Novartis Investigative Site Singapore 119228 Singapore Details
Novartis Investigative Site Singapore 168583 Singapore Details
Novartis Investigative Site Singapore 308433 Singapore Details
Novartis Investigative Site Bratislava 83310 Slovakia Details
Novartis Investigative Site Partizanske 958 03 Slovakia Details
Novartis Investigative Site Granada Andalucia 18014 Spain Details
Novartis Investigative Site Malaga Andalucia 29010 Spain Details
Novartis Investigative Site Badalona Catalunya 08916 Spain Details
Novartis Investigative Site Barcelona Catalunya 08035 Spain Details
Novartis Investigative Site Barcelona Catalunya 08036 Spain Details
Novartis Investigative Site San Sebastian Pais Vasco 20080 Spain Details
Novartis Investigative Site Las Palmas De Gran Canarias 35016 Spain Details
Novartis Investigative Site Madrid 28009 Spain Details
Novartis Investigative Site Madrid 28040 Spain Details
Novartis Investigative Site Madrid 28041 Spain Details
Novartis Investigative Site Madrid 28046 Spain Details
Novartis Investigative Site Valencia 46026 Spain Details
Novartis Investigative Site Zaragoza 50009 Spain Details
Novartis Investigative Site Stockholm 171 76 Sweden Details
Novartis Investigative Site Basel 4031 Switzerland Details
Novartis Investigative Site Kaohsiung 83301 Taiwan Details
Novartis Investigative Site Tainan 704 Taiwan Details
Novartis Investigative Site Taipei 10002 Taiwan Details
Novartis Investigative Site Taipei 11217 Taiwan Details
Novartis Investigative Site Taoyuan 333 Taiwan Details
Novartis Investigative Site Songkhla Hat Yai 90110 Thailand Details
Novartis Investigative Site Khon Kaen THA 40002 Thailand Details
Novartis Investigative Site Bangkok 10330 Thailand Details
Novartis Investigative Site Bangkok 10400 Thailand Details
Novartis Investigative Site Bangkok 10700 Thailand Details
Novartis Investigative Site Ankara 06100 Turkey Details
Novartis Investigative Site Edirne 22030 Turkey Details
Novartis Investigative Site Istanbul 34214 Turkey Details
Novartis Investigative Site High Heaton Newcastle Upon Tyne NE7 7DN United Kingdom Details
Novartis Investigative Site London NW3 2QG United Kingdom Details
Novartis Investigative Site Manchester M20 2BX United Kingdom Details
Novartis Investigative Site Plymouth PL6 8DH United Kingdom Details
Novartis Investigative Site Hanoi 100000 Vietnam Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field